Wolverine Trading
MDGL icon

Wolverine Trading’s Madrigal Pharmaceuticals MDGL Stock Holding History

Wolverine Trading’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$8.51M Buy
19,200
+3,500
+22% +$1.31M 0.01% 1020
2025
Q2 		$4.72M Sell
15,700
-7,400
-32% -$2.2M ﹤0.01% 1095
2025
Q1 		$7.57M Buy
23,100
+5,400
+31% +$1.77M 0.01% 767
2024
Q4 		$5.52M Buy
17,700
+7,900
+81% +$2.22M 0.01% 1131
2024
Q3 		$2.08M Sell
9,800
-1,700
-15% -$435K ﹤0.01% 1665
2024
Q2 		$3.22M Sell
11,500
-27,800
-71% -$6.62M ﹤0.01% 1259
2024
Q1 		$10.5M Buy
39,300
+13,300
+51% +$3.13M 0.01% 642
2023
Q4 		$6.02M Buy
26,000
+10,600
+69% +$1.85M 0.01% 975
2023
Q3 		$2.25M Sell
15,400
-1,600
-9% -$301K ﹤0.01% 1489
2023
Q2 		$3.74M Buy
17,000
+3,100
+22% +$840K ﹤0.01% 1074
2023
Q1 		$3.26M Buy
+13,900
New +$3.79M 0.01% 1074
2022
Q4 		– Sell
-14,500
Closed -$912K – 4616
2022
Q3 		$912K Buy
14,500
+9,900
+215% +$688K ﹤0.01% 2052
2022
Q2 		$331K Sell
4,600
-500
-10% -$36.8K ﹤0.01% 2971
2022
Q1 		$507K Sell
5,100
-7,900
-61% -$666K ﹤0.01% 3206
2021
Q4 		$1.1M Buy
13,000
+1,500
+13% +$123K ﹤0.01% 2506
2021
Q3 		$920K Buy
11,500
+6,600
+135% +$570K ﹤0.01% 3093
2021
Q2 		$476K Sell
4,900
-3,000
-38% -$355K ﹤0.01% 3772
2021
Q1 		$920K Sell
7,900
-2,300
-23% -$268K ﹤0.01% 2866
2020
Q4 		$1.13M Sell
10,200
-9,400
-48% -$1.15M ﹤0.01% 2238
2020
Q3 		$2.34M Buy
19,600
+6,300
+47% +$684K 0.01% 1353
2020
Q2 		$1.37M Buy
13,300
+10,000
+303% +$983K ﹤0.01% 1718
2020
Q1 		$231K Buy
+3,300
New +$275K ﹤0.01% 3517

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Wolverine Trading's MDGL Position: Q3 2025 in Review

Wolverine Trading increased its Madrigal Pharmaceuticals (MDGL) stake by 420% in Q3 2025, buying an estimated $1.52M and bringing the position to 5,056 shares worth $2.24M. The position accounts for ﹤0.01% of the portfolio, ranked #2071.

Wolverine Trading first reported a position in MDGL in Q2 2016 and has held it in 18 quarters since. 352 funds tracked by Wall St. Rank hold MDGL as of Q3 2025.

  • Wolverine Trading held 5,056 shares of Madrigal Pharmaceuticals worth $2.24M as of Q3 2025.
  • Wolverine Trading bought 4,084 Madrigal Pharmaceuticals shares in Q3 2025, an estimated $1.52M.
  • Madrigal Pharmaceuticals made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #2071 holding.
  • Wolverine Trading first reported a position in Madrigal Pharmaceuticals in Q2 2016 and has held it in 18 quarters since.
  • 352 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.